Step 1 topics → Gastrointestinal → GI Hormones (Gastrin, CCK, Secretin, GIP, Motilin, VIP, Somatostatin)

GI Hormones (Gastrin, CCK, Secretin, GIP, Motilin, VIP, Somatostatin)

USMLE Step 1 trap: Misattributes secretin release to gastric cells rather than duodenal S cells. Secretin is released from S cells of the duodenum in response to acidic chyme and fatty acids.

GI hormones are a favorite USMLE Step 1 topic, and the most reliable error is conflating CCK with secretin — two duodenal hormones that both respond to chyme and both affect the pancreas, but at entirely different cell targets with entirely different outputs. The core task is knowing each hormone's source cell, stimulus, and effect — but the exam rarely asks that directly. Instead, it gives you a clinical scenario (acid hitting the duodenum, fat in a meal, a secretory diarrhea case) and expects you to trace which hormone is triggered and what downstream effect follows. Seven hormones dominate: gastrin, CCK, secretin, GIP, motilin, VIP, and somatostatin.

CCK drives enzyme release from acinar cells and contracts the gallbladder; secretin drives bicarbonate secretion from ductal cells to neutralize acid. A second common trap is misattributing secretin's source to gastric cells (chief or G cells) — secretin comes from S cells of the duodenum, full stop.

On the clinical side, USMLE Step 1 tests hormone-secreting tumors (gastrinoma, VIPoma, carcinoid) and octreotide's role in managing them. Students misread octreotide as a receptor blocker — it's not. It's a somatostatin analogue that suppresses hormone secretion at the tumor source. Gastrinoma vignettes also trip people up when ulcers appear in atypical locations; if you expect peptic ulcers only in the duodenal bulb, you'll miss the diagnosis.

From real student decks
95%have cards covering this topic
89%have mature cards
1median lapses in 14 days

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: Secretin is released from chief cells or G cells of the stomach.
Right: Secretin is released from S cells of the duodenum in response to acidic chyme and fatty acids.
Secretin comes from S cells located in the duodenum, not from any gastric cell. Chief cells secrete pepsinogen; G cells (also gastric) secrete gastrin. The trigger for secretin is acidic chyme (and fatty acids) entering the duodenum — it's a duodenal response to gastric output, which is why it makes physiologic sense that its source is downstream of the stomach.
Common mistake
Wrong: CCK and secretin both primarily stimulate pancreatic enzyme secretion.
Right: CCK primarily stimulates pancreatic enzyme (acinar) secretion and gallbladder contraction, while secretin primarily stimulates pancreatic ductal bicarbonate secretion to neutralize duodenal acid.
Both hormones reach the pancreas, but they hit different cell types with different effects. CCK acts on acinar cells to release digestive enzymes (lipase, proteases, amylase) and on the gallbladder smooth muscle to trigger bile ejection. Secretin acts on ductal epithelial cells to secrete bicarbonate-rich fluid that neutralizes the acid delivered by gastric emptying. Think of it this way: CCK brings the tools to digest the meal, secretin buffers the environment so digestion can actually happen.
Common mistake
Wrong: Zollinger-Ellison syndrome causes ulcers only in the duodenal bulb, like ordinary peptic ulcer disease.
Right: Gastrinoma causes multiple ulcers in atypical locations (distal duodenum, jejunum) due to massive hypergastrinemia-driven acid hypersecretion.
Normal peptic ulcers form in the duodenal bulb because that's where acid first contacts intestinal mucosa. In Zollinger-Ellison syndrome, a gastrinoma produces massive, unregulated gastrin, driving acid hypersecretion that overwhelms the normal buffering capacity of the proximal duodenum and extends injury further downstream. The result is ulcers in atypical locations — distal duodenum, jejunum — and often multiple ulcers. If you see ulcers beyond the bulb or recurrent ulcers despite treatment, think gastrinoma.
Common mistake
Wrong: Octreotide works by blocking hormone receptors on target organs.
Right: Octreotide is a somatostatin analogue that inhibits release of multiple GI hormones (gastrin, VIP, glucagon, insulin) from neuroendocrine tumor cells.
Octreotide does not block receptors on target organs. It is a synthetic analogue of somatostatin, and it works by binding somatostatin receptors on neuroendocrine tumor cells themselves, suppressing the secretion of whatever hormone the tumor overproduces — whether that's gastrin, VIP, glucagon, or insulin. The effect is upstream: less hormone is released into circulation, so downstream target organs are no longer overstimulated. This is why octreotide is broadly useful across multiple GI tumor types.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. For each major GI hormone, identify the source cell or tissue, the stimulus that triggers its release, and its primary physiologic action — this is the foundation everything else builds on.
  2. Distinguish CCK from secretin by their specific duodenal stimuli (fat and protein vs. acid), their distinct pancreatic targets (acinar enzyme secretion vs. ductal bicarbonate secretion), and CCK's additional role in gallbladder contraction.
  3. Recognize hormone-secreting GI tumors (gastrinoma/Zollinger-Ellison, VIPoma/WDHA syndrome, carcinoid) by their clinical presentations, and explain how octreotide treats them via somatostatin-mediated inhibition of hormone secretion.

Can you avoid these mistakes?

A patient eats a fatty meal. Trace the sequence: which duodenal hormone is released, from what cell, and what are its two main downstream effects on digestion?
You see a patient with watery diarrhea, hypokalemia, and achlorhydria (no stomach acid). What hormone excess explains this picture, and what is the tumor called?
A patient with recurrent peptic ulcers has ulcers found in the distal duodenum and proximal jejunum on endoscopy. Why does this location pattern point away from ordinary H. pylori ulcer disease, and what is the likely diagnosis?
Acid chyme enters the duodenum. Two hormones are released. One stimulates pancreatic bicarbonate secretion; the other stimulates pancreatic enzyme secretion. Name each hormone, its source cell, and its specific pancreatic target cell type.

Related topics

Gut Tube Regions and Blood Supply Midgut Rotation and Anomalies (Malrotation/Volvulus) Meckel Diverticulum Omphalocele vs Gastroschisis

See how your Anki deck covers this topic.

Upload your deck for a free audit →